共 50 条
- [45] Safety and efficacy of pegylated interferon α-2a and ribavirin for the treatment of hepatitis C in patients with thalassemia HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 (08): : 1247 - 1251
- [46] A Bayesian Approach for Population Pharmacokinetic Modeling of Pegylated Interferon α-2a in Hepatitis C Patients Clinical Pharmacokinetics, 2017, 56 : 1369 - 1379
- [47] The Response to Pegylated Interferon Alpha 2a in Haemodialysis Patients with Hepatitis C Virus Infection Infection, 2008, 36 : 341 - 344